Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001206774-22-001086
Filing Date
2022-04-12
Accepted
2022-04-12 16:31:27
Documents
10

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL PROXY SOLICITING MATERIALS bmrn3994571-defa14a.htm DEFA14A 30022
2 GRAPHIC bmrn-logo.jpg GRAPHIC 31885
3 GRAPHIC bmrn3994571-noticesx1x1.jpg GRAPHIC 58857
4 GRAPHIC bmrn3994571-noticesx1x2.jpg GRAPHIC 5163
5 GRAPHIC bmrn3994571-noticesx1x3.jpg GRAPHIC 3186
6 GRAPHIC bmrn3994571-noticesx1x4.jpg GRAPHIC 7360
7 GRAPHIC bmrn3994571-noticesx1x5.jpg GRAPHIC 6871
8 GRAPHIC bmrn3994571-noticesx2x1.jpg GRAPHIC 1098
9 GRAPHIC bmrn3994571-noticesx2x1a.jpg GRAPHIC 1098
10 GRAPHIC bmrn3994571-noticesx2x1b.jpg GRAPHIC 1098
  Complete submission text file 0001206774-22-001086.txt   192921
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 22822638
SIC: 2834 Pharmaceutical Preparations